Want to join the conversation?
Pharmaceutical company $SGNT said it has entered into an agreement with Teva Pharmaceutical Industries Ltd. and Actavis LLC to acquire a portfolio of five Abbreviated New Drug Applications (ANDAs) in the US for $40MM. The acquisition is contingent on the closing of the Teva/Allergan generics deal and approval by the US FTC of $SGNT as a buyer.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.